Searched for
GLOBALLY MONOCLONAL ANTIBODY
Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...10 May, 2026, 08.50 AM IST- India to procure 20 more doses of monoclonal antibody from Australia for Nipah treatment: ICMR DGIndia will procure an additional 20 doses of monoclonal antibody from Australia for the treatment of Nipah virus infection, according to Ra...15 Sep, 2023, 11.02 PM IST
- Roche Pharma launches drug to treat breast cancerPHESGO was first approved by the US FDA in June 2020 during the peak of the Covid pandemic, by the European Medicines Agency (EMA) in Decem...12 May, 2022, 06.25 PM IST
- India may have to wait longer for Pfizer, GSK's Covid drugsLast month Pfizer had announced an agreement with the UN's Medicines Patent Pool (MPP) for licensing antiviral intellectual property to MPP...31 Dec, 2021, 06.48 AM IST
- Glenmark's subsidiary Ichnos Sciences enters pact with Almirall for novel drug to treat autoimmune diseasesUnder the agreement, Almirall is granted global rights to develop and commercialize this monoclonal antibody for autoimmune diseases. Ichno...14 Dec, 2021, 01.46 PM IST
- Delta plus: New Covid variant identified, experts say no cause of concern for nowThough there is no indication yet of the severity of the disease due to the new variant, Delta plus is resistant to the monoclonal antibody...14 Jun, 2021, 05.47 PM IST
- 'Next-gen' COVID-19 vaccines may be needed to tackle emerging variants, say scientistsWork on vaccines will have to continue on parallel tracks - one to tackle the SARS-CoV-2 virus with first generation vaccines and the other...28 Jan, 2021, 12.09 PM IST
- IAVI, Merck KGaA, Serum Institute join hands to develop monoclonal antibodies for Covid-19A phase-I clinical trial is expected to start in early 2021.23 Oct, 2020, 09.40 AM IST
- Three local cos working on antibody drugs for CovidBharat Serums, Intas Pharma and Biological E along with ICMR are working on antibody therapies for Covid-19 in India.13 Oct, 2020, 11.59 PM IST
- What are antibody therapies and who is developing them for COVID-19?More recently, scientists have developed treatments called monoclonal antibodies -- antibodies that can be isolated and manufactured in lar...09 Jun, 2020, 12.56 PM IST
- Bharat Bio leads CSIR project to develop human antibodiesThis programme brings together academia — National Centre for Cell Science, Indian Institute of Technology, Indore, and industry – PredOmix...09 May, 2020, 09.44 AM IST
- Serum eyes Rs 10,000 crore revenues by 2022, unveils new vaccinesThe company is also developing vaccine and drug for dengue fever. It has commenced first phase of trials in Singapore and hopes to launch v...31 Oct, 2017, 07.25 PM IST
- Rabishield: First fast-acting anti-rabies drug set for India launchRMAb has been developed by Pune-based Serum Institute of India (SII) and US-based Mass Biologics of the University of Massachusetts Medical...24 Feb, 2016, 12.51 PM IST
- Glenmark Pharmaceuticals completes phase I clinical trials for antibodyGlenmark Pharmaceuticals has completed the clinical phase I studies for its novel monoclonal antibody 'GBR 830' for treating autoimmune dis...03 Sep, 2015, 07.10 PM IST
- NeuClone to collaborate with Serum Institute of India; to supply drugs globallyNeuClone has retained licence to the jointly developed biosimilars for the developed markets of USA, Europe, Canada, Australia, Taiwan.17 Jul, 2014, 01.15 PM IST
- Biotech drugs to replace chemical entities Lipitor & Plavix as market leadersThe global pecking order of blockbusters may soon be heading for a major upheaval with biotech drugs toppling the present market leaders.26 Nov, 2010, 09.39 AM IST
- World's first anti-EGFR cancer antibody launchedBiotechnology behemoth Biocon has launched BIOMAb-EGFR, a therapeutic monoclonal antibody-based drug for treating solid tumours of epitheli...18 Sep, 2006, 01.34 AM IST
Load More
